Advanced

Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis.

Dillner, Joakim LU (2005) In Clinical Chemistry 51(10). p.1768-1769
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Clinical Chemistry
volume
51
issue
10
pages
1768 - 1769
publisher
American Association for Clinical Chemistry
external identifiers
  • wos:000232198600005
  • scopus:25444530887
ISSN
0009-9147
DOI
10.1373/clinchem.2005.055483
language
English
LU publication?
yes
id
7ced510a-3846-47df-8438-04a4dce52147 (old id 145007)
alternative location
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16189377&dopt=Abstract
date added to LUP
2007-07-24 14:14:15
date last changed
2017-01-01 05:01:31
@article{7ced510a-3846-47df-8438-04a4dce52147,
  author       = {Dillner, Joakim},
  issn         = {0009-9147},
  language     = {eng},
  number       = {10},
  pages        = {1768--1769},
  publisher    = {American Association for Clinical Chemistry},
  series       = {Clinical Chemistry},
  title        = {Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis.},
  url          = {http://dx.doi.org/10.1373/clinchem.2005.055483},
  volume       = {51},
  year         = {2005},
}